• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZNO
Click for more information
7.69% 2.4¢

ZOONO GROUP LIMITED - Announcements

Market Cap $9.241M  ! watchlist Created with Sketch. Add to my watchlist

Zoono Group Limited is an Australia-based global biotech company that develops,... Zoono Group Limited is an Australia-based global biotech company that develops, manufactures and distributes a suite of antimicrobial solutions in multiple countries. The Company produces sprays, wipes and foams suited for skin care, surface sanitizers and mold remediation treatments. Its products are based on the ZOONO molecule, an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The Company markets its products in various countries, including Australasia, Asia, United States, India, United Kingdom and Europe. Its subsidiaries include Zoono Group Limited (NZ), Zoono Limited, Zoono Holdings Limited (UK), Zoono EU Limited, Zoono (Shanghai) Biotech Co. Limited, Zoono Holdings USA LLC and Zoono South Africa (Pty) Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ZNO Quarterly Cashflow Report-GSE.AX 28/10/16
ZNO Appendix 4G-GSE.AX 30/09/16
ZNO Annual Report to shareholders-GSE.AX 30/09/16
ZNO Goldsearch Signs Binding Share Sale Agreement with Zoono-GSE.AX 19/08/16
ZNO Quarterly Cashflow Report-GSE.AX 29/07/16
ZNO Quarterly Activities Report-GSE.AX 29/07/16
ZNO Suspension from Official Quotation-GSE.AX PRICE SENSITIVE27/06/16
ZNO Goldsearch Signs Term Sheet with Zoono Group-GSE.AX PRICE SENSITIVE27/06/16
ZNO Appendix 3B-GSE.AX 24/06/16
ZNO Appendix 3B-GSE.AX 24/06/16
ZNO Placement-GSE.AX 24/06/16
ZNO Placement-GSE.AX 24/06/16
ZNO Ceasing to be a substantial holder-GSE.AX 09/06/16
ZNO Ceasing to be a substantial holder-GSE.AX 08/06/16
ZNO Appendix 3B-GSE.AX 31/05/16
ZNO Placement-GSE.AX PRICE SENSITIVE31/05/16
ZNO Initial Director's Interest Notice-GSE.AX 11/05/16
ZNO Final Director's Interest Notice-GSE.AX 11/05/16
ZNO Director Appointment/Resignation-GSE.AX 11/05/16
ZNO Quarterly Activities Report-GSE.AX PRICE SENSITIVE29/04/16
ZNO Quarterly Cashflow Report-GSE.AX PRICE SENSITIVE29/04/16
ZNO Reinstatement to Official QuotationPRICE SENSITIVE18/03/16
ZNO Half Yearly Report and Accounts18/03/16
ZNO Response to ASX Half Year Report Letter17/03/16
ZNO Suspension from Official QuotationPRICE SENSITIVE16/03/16
ZNO Quarterly Cashflow ReportPRICE SENSITIVE29/01/16
ZNO Quarterly Activities ReportPRICE SENSITIVE29/01/16
ZNO Final Director's Interest Notice21/12/15
ZNO Results of Meeting18/12/15
ZNO Company Update09/12/15
ZNO Notice of Annual General Meeting/Proxy Form17/11/15
ZNO Extension of time to hold the Annual General Meeting13/11/15
ZNO Appendix 4G02/11/15
ZNO Corporate Governance Statement02/11/15
ZNO Annual Report to shareholders02/11/15
ZNO Quarterly Cashflow ReportPRICE SENSITIVE28/10/15
ZNO Quarterly Activities ReportPRICE SENSITIVE28/10/15
ZNO Appendix 3B22/10/15
ZNO Initial Director's Interest Notice12/10/15
ZNO Director Appointment12/10/15
ZNO Becoming a substantial holder14/09/15
ZNO Becoming a substantial holder07/09/15
ZNO Annual Report to shareholders01/09/15
ZNO Becoming a substantial holder27/08/15
ZNO Appendix 3B13/08/15
ZNO Completion of $500,000 Placement13/08/15
ZNO Initial Director's Interest Notice30/07/15
ZNO Final Director's Interest Notice30/07/15
ZNO Quarterly Activities ReportPRICE SENSITIVE28/07/15
ZNO Quarterly Cashflow ReportPRICE SENSITIVE28/07/15
ZNO Director Appointment/Resignation24/07/15
ZNO Results of Meeting16/07/15
ZNO Address to Shareholders from Directors16/07/15
ZNO Notice of Extraordinary General Meeting/Proxy Form17/06/15
ZNO Notice of Extraordinary General Meeting/Proxy Form17/06/15
ZNO Consolidation and PlacementPRICE SENSITIVE11/06/15
ZNO Change of registry address15/05/15
ZNO Up Dated Appendix 3B15/05/15
ZNO Appendix 3B13/05/15
ZNO National Health Services Acquisition - UpdatePRICE SENSITIVE08/04/15
ZNO Appendix 3B20/03/15
ZNO Appendix 3X20/03/15
ZNO Appendix 3X20/03/15
ZNO Appendix 3Z - Terry Willsteed20/03/15
ZNO New Venture and Director Appointment/ResignationPRICE SENSITIVE19/03/15
ZNO Appendix 3Z19/03/15
ZNO Reinstatement to Official QuotationPRICE SENSITIVE18/03/15
ZNO Half Yearly Report and Accounts17/03/15
ARH +Suspension from Official QuotationPRICE SENSITIVE17/03/15
ZNO Resignation of Director11/03/15
ZNO Share Purchase Plan - Closing Date Extension20/02/15
ZNO Appendix 5BPRICE SENSITIVE29/01/15
ZNO Quarterly Activity ReportPRICE SENSITIVE29/01/15
ZNO Share Purchase Plan - Closing Date Extension16/01/15
ZNO Termination of NHS Heads of AgreementPRICE SENSITIVE19/12/14
ZNO Share Purchase Plan - Extension of Closing Date19/12/14
ZNO Appendix 3B18/12/14
ZNO Share Purchase Plan09/12/14
ZNO Placement and Share Purchase Plan08/12/14
ZNO Cleansing Statement08/12/14
ZNO Results of AGM28/11/14
ZNO National Health Services Acquisition of Galen & GrayPRICE SENSITIVE25/11/14
ZNO Reinstatement to Official QuotationPRICE SENSITIVE04/11/14
ZNO Quarterly Activity Report03/11/14
ZNO Quarterly Cashflow03/11/14
ZNO +Suspension from Official QuotationPRICE SENSITIVE03/11/14
ZNO Annual Report29/10/14
ZNO RingMD - Non-Binding Memorandum of UnderstandingPRICE SENSITIVE28/10/14
ZNO Proxy Form for AGM27/10/14
ZNO AGM Notice of Meeting27/10/14
AKN +Exploration Program and General UpdatePRICE SENSITIVE20/10/14
ZNO Heads of Agreement - National Health ServicePRICE SENSITIVE08/10/14
ZNO Termination of Horizon Healthcare Solutions AgreementPRICE SENSITIVE03/10/14
ZNO Annual Report30/09/14
ZNO Shareholder Update - Acquisition of Horizon HealthcarePRICE SENSITIVE11/08/14
ZNO Quarterly Activity StatementPRICE SENSITIVE30/07/14
ZNO Quarterly Cashflow StatementPRICE SENSITIVE30/07/14
AKN +2014 Exploration Program and General UpdatePRICE SENSITIVE15/07/14
ZNO Notice of Meeting - Other11/07/14
ZNO Appendix 3X and 3Z notices09/07/14
ZNO Quarterly Cashflow Report-GSE.AX
28/10/16
ZNO Appendix 4G-GSE.AX
30/09/16
ZNO Annual Report to shareholders-GSE.AX
30/09/16
ZNO Goldsearch Signs Binding Share Sale Agreement with Zoono-GSE.AX
19/08/16
ZNO Quarterly Cashflow Report-GSE.AX
29/07/16
ZNO Quarterly Activities Report-GSE.AX
29/07/16
ZNO Suspension from Official Quotation-GSE.AX
27/06/16PRICE SENSITIVE
ZNO Goldsearch Signs Term Sheet with Zoono Group-GSE.AX
27/06/16PRICE SENSITIVE
ZNO Appendix 3B-GSE.AX
24/06/16
ZNO Appendix 3B-GSE.AX
24/06/16
ZNO Placement-GSE.AX
24/06/16
ZNO Placement-GSE.AX
24/06/16
ZNO Ceasing to be a substantial holder-GSE.AX
09/06/16
ZNO Ceasing to be a substantial holder-GSE.AX
08/06/16
ZNO Appendix 3B-GSE.AX
31/05/16
ZNO Placement-GSE.AX
31/05/16PRICE SENSITIVE
ZNO Initial Director's Interest Notice-GSE.AX
11/05/16
ZNO Final Director's Interest Notice-GSE.AX
11/05/16
ZNO Director Appointment/Resignation-GSE.AX
11/05/16
ZNO Quarterly Activities Report-GSE.AX
29/04/16PRICE SENSITIVE
ZNO Quarterly Cashflow Report-GSE.AX
29/04/16PRICE SENSITIVE
ZNO Reinstatement to Official Quotation
18/03/16PRICE SENSITIVE
ZNO Half Yearly Report and Accounts
18/03/16
ZNO Response to ASX Half Year Report Letter
17/03/16
ZNO Suspension from Official Quotation
16/03/16PRICE SENSITIVE
ZNO Quarterly Cashflow Report
29/01/16PRICE SENSITIVE
ZNO Quarterly Activities Report
29/01/16PRICE SENSITIVE
ZNO Final Director's Interest Notice
21/12/15
ZNO Results of Meeting
18/12/15
ZNO Company Update
09/12/15
ZNO Notice of Annual General Meeting/Proxy Form
17/11/15
ZNO Extension of time to hold the Annual General Meeting
13/11/15
ZNO Appendix 4G
02/11/15
ZNO Corporate Governance Statement
02/11/15
ZNO Annual Report to shareholders
02/11/15
ZNO Quarterly Cashflow Report
28/10/15PRICE SENSITIVE
ZNO Quarterly Activities Report
28/10/15PRICE SENSITIVE
ZNO Appendix 3B
22/10/15
ZNO Initial Director's Interest Notice
12/10/15
ZNO Director Appointment
12/10/15
ZNO Becoming a substantial holder
14/09/15
ZNO Becoming a substantial holder
07/09/15
ZNO Annual Report to shareholders
01/09/15
ZNO Becoming a substantial holder
27/08/15
ZNO Appendix 3B
13/08/15
ZNO Completion of $500,000 Placement
13/08/15
ZNO Initial Director's Interest Notice
30/07/15
ZNO Final Director's Interest Notice
30/07/15
ZNO Quarterly Activities Report
28/07/15PRICE SENSITIVE
ZNO Quarterly Cashflow Report
28/07/15PRICE SENSITIVE
ZNO Director Appointment/Resignation
24/07/15
ZNO Results of Meeting
16/07/15
ZNO Address to Shareholders from Directors
16/07/15
ZNO Notice of Extraordinary General Meeting/Proxy Form
17/06/15
ZNO Notice of Extraordinary General Meeting/Proxy Form
17/06/15
ZNO Consolidation and Placement
11/06/15PRICE SENSITIVE
ZNO Change of registry address
15/05/15
ZNO Up Dated Appendix 3B
15/05/15
ZNO Appendix 3B
13/05/15
ZNO National Health Services Acquisition - Update
08/04/15PRICE SENSITIVE
ZNO Appendix 3B
20/03/15
ZNO Appendix 3X
20/03/15
ZNO Appendix 3X
20/03/15
ZNO Appendix 3Z - Terry Willsteed
20/03/15
ZNO New Venture and Director Appointment/Resignation
19/03/15PRICE SENSITIVE
ZNO Appendix 3Z
19/03/15
ZNO Reinstatement to Official Quotation
18/03/15PRICE SENSITIVE
ZNO Half Yearly Report and Accounts
17/03/15
ARH +Suspension from Official Quotation
17/03/15PRICE SENSITIVE
ZNO Resignation of Director
11/03/15
ZNO Share Purchase Plan - Closing Date Extension
20/02/15
ZNO Appendix 5B
29/01/15PRICE SENSITIVE
ZNO Quarterly Activity Report
29/01/15PRICE SENSITIVE
ZNO Share Purchase Plan - Closing Date Extension
16/01/15
ZNO Termination of NHS Heads of Agreement
19/12/14PRICE SENSITIVE
ZNO Share Purchase Plan - Extension of Closing Date
19/12/14
ZNO Appendix 3B
18/12/14
ZNO Share Purchase Plan
09/12/14
ZNO Placement and Share Purchase Plan
08/12/14
ZNO Cleansing Statement
08/12/14
ZNO Results of AGM
28/11/14
ZNO National Health Services Acquisition of Galen & Gray
25/11/14PRICE SENSITIVE
ZNO Reinstatement to Official Quotation
04/11/14PRICE SENSITIVE
ZNO Quarterly Activity Report
03/11/14
ZNO Quarterly Cashflow
03/11/14
ZNO +Suspension from Official Quotation
03/11/14PRICE SENSITIVE
ZNO Annual Report
29/10/14
ZNO RingMD - Non-Binding Memorandum of Understanding
28/10/14PRICE SENSITIVE
ZNO Proxy Form for AGM
27/10/14
ZNO AGM Notice of Meeting
27/10/14
AKN +Exploration Program and General Update
20/10/14PRICE SENSITIVE
ZNO Heads of Agreement - National Health Service
08/10/14PRICE SENSITIVE
ZNO Termination of Horizon Healthcare Solutions Agreement
03/10/14PRICE SENSITIVE
ZNO Annual Report
30/09/14
ZNO Shareholder Update - Acquisition of Horizon Healthcare
11/08/14PRICE SENSITIVE
ZNO Quarterly Activity Statement
30/07/14PRICE SENSITIVE
ZNO Quarterly Cashflow Statement
30/07/14PRICE SENSITIVE
AKN +2014 Exploration Program and General Update
15/07/14PRICE SENSITIVE
ZNO Notice of Meeting - Other
11/07/14
ZNO Appendix 3X and 3Z notices
09/07/14
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
2.4¢ 		Change
-0.002(7.69%) 		Mkt cap ! $9.241M
Open High Low Value Volume
2.6¢ 2.6¢ 2.4¢ $19.68K 798.8K

Buyers (Bids)

No. Vol. Price($)
2 330000 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 76232 2
View Market Depth
Last trade - 15.49pm 25/11/2024 (20 minute delay) ?
Last
2.5¢ 		  Change
-0.002 ( 2.72 %)
Open High Low Volume
2.6¢ 2.6¢ 2.5¢ 90232
Last updated 15.49pm 25/11/2024 ?
ZNO (ASX) Chart

Top Stories

Tambourah chases gold veins and mineralisation extension with drilling

Tambourah Metals Ltd has discovered two high-grade gold veins through a diamond drilling program in Western Australia
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.